Breaking News
Investing Pro 0
💎 Access the Market Tools Trusted by Thousands of Investors Get Started

ImmunoGen shares jump after Barclays raises price target of biotech firm

Published Jun 09, 2023 21:42
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters
 
IMGN
+2.02%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

Investing.com -- Shares in ImmunoGen (NASDAQ:IMGN) jumped in early trading on Friday after analysts at Barclays raised their price target for the stock to $20 from $9, citing positive commentary around the biotech company's ovarian cancer treatment.

In a note to clients, the Barclays analysts said data presented by the firm for its Elahere ovarian cancer drug at the recent American Society of Clinical Oncology conference were "well received," adding that some observers believe the treatment can be "practice changing."

ImmunoGen previously announced in May that a late-stage trial showed that Elahere helped extend the lives of patients without the cancer worsening, particularly when compared to chemotherapy. Analysts at Truist Securities told Reuters at the time the result was a "home run" for ImmunoGen and all but removes doubt that the drug candidate will eventually receive approval from U.S. drug regulators.

Elsewhere on Friday, ImmunoGen announced updated interim results of a Phase 2 trial of its pivekimab for people with a rare blood cancer. The co-investigator of the study said there was "impressive anti-tumor activity and durable responses" in both frontline and relapsed patients, adding that pivekimab has the potential to be a "promising, novel option for this challenging disease."

When measuring from Thursday's closing price, shares in ImmunoGen have now climbed 217% so far this year.

ImmunoGen shares jump after Barclays raises price target of biotech firm
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email